CMG
51
-3
NRG
69
12
TAP
45
-6
SJM
38
-3
XYL
54
-4
VLO
40
-5
KHC
59
14
BWA
45
-4
ADT
32
9
VRSN
53
-2
INTC
43
6
HON
47
-12
NEM
48
2
LEG
27
-2
ETR
68
2
MU
34
3
CNX
80
4
AEP
58
2
DHI
53
-3
UA
32
8
CMG
51
-3
NRG
69
12
TAP
45
-6
SJM
38
-3
XYL
54
-4
VLO
40
-5
KHC
59
14
BWA
45
-4
ADT
32
9
VRSN
53
-2
INTC
43
6
HON
47
-12
NEM
48
2
LEG
27
-2
ETR
68
2
MU
34
3
CNX
80
4
AEP
58
2
DHI
53
-3
UA
32
8
Financhill
Back

Invesco S&P SmallCap Cnsmr Discret ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
55

PSCD
Invesco S&P SmallCap Cnsmr Discret ETF

Last Price:
111.19
Seasonality Move:
7.19%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Buy
55
Invesco S&P SmallCap Cnsmr Discret ETF (PSCD) is a Buy

Is Invesco S&P SmallCap Cnsmr Discret ETF a Buy, Sell or Hold?

  • The current Invesco S&P SmallCap Cnsmr Discret ETF [PSCD] share price is $109.83. The Score for PSCD is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • PSCD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

PSCD Stock Price Chart

What is Invesco S&P SmallCap Cnsmr Discret ETF's stock price today?

  • The Invesco S&P SmallCap Cnsmr Discret ETF share price today is $109.83
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PSCD is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

PSCD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.17 Buy
Relative Strength Index (14 RSI): 61.19 Buy
Chaikin Money Flow: -1562 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.27 - 108.63) Buy
Bollinger Bands (100): (101.06 - 107.16) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

PSCD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 107.25 Buy
20-day SMA: 106.07 Buy
50-day SMA: 105.47 Buy
200-day SMA: 103.08 Buy
8-day EMA: 108.01 Buy
20-day EMA: 106.35 Buy
50-day EMA: 105.19 Buy
200-day EMA: 101.6 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Invesco S&P SmallCap Cnsmr Discret ETF Earnings Growth & PSCD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Invesco S&P SmallCap Cnsmr Discret ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):